Condition: Hyperlipidemia · Sponsor: Merck Sharp & Dohme LLC
Researchers designed a study medicine called enlicitide to lower low-density lipoprotein cholesterol (LDL-C). In this study, researchers want to learn about giving enlicitide with another medicine called rosuvastatin. Rosuvastatin is a standard (usual) treatment to lower LDL-C. The goal of this study is to learn if enlicitide given with rosuvastatin works better than placebo on lowering LDL-C in a person's blood. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of a study medicine.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Central Research Associates ( Site 0009) | Birmingham, Alabama, United States | — |
| G&L Research ( Site 0024) | Foley, Alabama, United States | — |
| Synexus Clinical Research US, Inc. - Phoenix Central ( Site 0030) | Phoenix, Arizona, United States | — |
| Alliance for Multispecialty Research LLC ( Site 0049) | Tempe, Arizona, United States | — |
| Chemidox Clinical Trials ( Site 0008) | Lancaster, California, United States | — |
| Clinical Trials Research ( Site 0036) | Sacramento, California, United States | — |
| Legacy Clinical Trials ( Site 0044) | Colorado Springs, Colorado, United States | — |
| Alliance for Multispecialty Research, LLC ( Site 0040) | Fort Myers, Florida, United States | — |
| Soffer Health Institute ( Site 0046) | Hollywood, Florida, United States | — |
| East Coast Institute for Research ( Site 0041) | Lake City, Florida, United States | — |
| Inpatient Research Clinic ( Site 0017) | Miami Lakes, Florida, United States | — |
| Clinical Research Trials of Florida ( Site 0001) | Tampa, Florida, United States | — |
+ 77 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.